Overview

A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Co

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
A phase 4 trial evaluating the effect and safety of ILUVIEN in chronic DME patients insufficiently responsive to available therapies.
Phase:
Phase 4
Details
Lead Sponsor:
Alimera Sciences
Treatments:
Bevacizumab
Fluocinolone Acetonide